COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen(R) in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore
(NASDAQ:CSCI),(TSX:CSCI),(Pinksheets:CSCIF),(PinkSheets:CSCIF), TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company“), a life sciences company focused on pharmaceutical therapies, diagnostic products, and natural ingredients solutions, today announced that its wholly-owned subsidiary, Aeterna Zentaris GmbH, has entered into an exclusive distribution agreement with Wuzhou Drug International Trading […]